分子对接:一种用于发现针对内脏莱什曼病的新目标的计算方法
Vinita Gouri1, Akanksha Kanojia2, Awanish Kumar3
1Department of Zoology, Kumaun University, Nainital, India.
Journal of molecular modeling
|February 17, 2026
概括
对内脏莱什曼病 (VL) 的计算药物发现显示出有希望. 分子对接识别了潜在的Leishmania donovani候选药物,在体外和体内得到验证,提供了具有成本效益的方法.
科学领域:
- 寄生虫学的寄生虫学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 莱什曼尼亚多诺瓦尼 (Leishmania donovani) 引起内脏莱什曼尼亚病 (VL),这是一个致命的全球健康问题.
- 耐药性需要针对VL的新型治疗策略.
- 计算方法加快了新的抗莱什曼药物候选药物的识别.
研究的目的:
- 对Leishmania目标进行in silico分子对接研究进行审查.
- 要突出具有验证的体外和体外抗莱什曼活性的化合物.
- 强调计算方法在抗莱什曼病药物开发中的价值.
主要方法:
- 专注于分子对接,以识别与莱什马尼亚蛋白质具有高结合亲和力的化合物.
- 包括在体外和体内验证抗莱什曼化合物的研究.
- 讨论药物发现中使用的各种分子对接软件.
主要成果:
- 通过in silico选确定了潜在的候选药物.
- 突出显示的化合物在体外和体内表现出对Leishmania的有效性.
- 证明了计算查在优先考虑候选药物的实用性.
结论:
- 计算方法,特别是分子对接,对于识别抗莱什曼病候选药物的有效.
- 与传统方法相比,in silico选显著减少了时间和成本.
- 这一审查支持在抗莱什曼病药物发现管道的早期整合计算方法.
更多相关视频
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
1.3K
08:17Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
1.9K
相关概念视频
Ligand Binding Sites
15.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.3K
Drug Discovery: Overview
12.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.1K
